Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

SBC Medical Group Holdings (SBCWW) Invested Capital (2023 - 2025)

Historic Invested Capital for SBC Medical Group Holdings (SBCWW) over the last 3 years, with Q3 2025 value amounting to $248.3 million.

  • SBC Medical Group Holdings' Invested Capital rose 2075.61% to $248.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $248.3 million, marking a year-over-year increase of 2075.61%. This contributed to the annual value of $209.5 million for FY2024, which is 4551.95% up from last year.
  • As of Q3 2025, SBC Medical Group Holdings' Invested Capital stood at $248.3 million, which was up 2075.61% from $245.0 million recorded in Q2 2025.
  • SBC Medical Group Holdings' Invested Capital's 5-year high stood at $248.3 million during Q3 2025, with a 5-year trough of -$4.2 million in Q2 2023.
  • Its 3-year average for Invested Capital is $129.2 million, with a median of $174.8 million in 2023.
  • Over the last 5 years, SBC Medical Group Holdings' Invested Capital had its largest YoY gain of 267421.27% in 2025, and its largest YoY loss of 2075.61% in 2025.
  • Over the past 3 years, SBC Medical Group Holdings' Invested Capital (Quarter) stood at $144.0 million in 2023, then skyrocketed by 45.52% to $209.5 million in 2024, then rose by 18.54% to $248.3 million in 2025.
  • Its Invested Capital stands at $248.3 million for Q3 2025, versus $245.0 million for Q2 2025 and $226.8 million for Q1 2025.